Anika Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.08 | -$0.08 | -$0.08 |
| Q2 2024 | 1 | $0.07 | $0.07 | $0.07 |
| Q3 2024 | 1 | $0.09 | $0.09 | $0.09 |
| Q4 2024 | 1 | -$0.23 | -$0.22 | -$0.23 |
| Q1 2025 | 1 | -$0.04 | -$0.03 | -$0.04 |
| Q2 2025 | 1 | $0.02 | $0.03 | $0.03 |
| Q3 2025 | 1 | $0.03 | $0.03 | $0.03 |
| Q4 2025 | 1 | $0.09 | $0.10 | $0.10 |
Anika Therapeutics, Inc. Earnings Date And Information
Anika Therapeutics, Inc. last posted its earnings results on Thursday, October 31st, 2024. The company reported $-0.25 earnings per share for the quarter, missing analysts' consensus estimates of $0.3 by $0.55. The company had revenue of 38.75 M for the quarter and had revenue of 166.66 M for the year. Anika Therapeutics, Inc. has generated $-6 earnings per share over the last year ($-5.64 diluted earnings per share) and currently has a price-to-earnings ratio of -2.57. Anika Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 20th, 2025 based on prior year's report dates.
Anika Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/04/2024 | Q3 2024 | -$2.03 | $42.08 M | $38.75 M | ||
| 08/08/2024 | Q2 2024 | $0.23 | -$0.01 | -0.24 | $40.77 M | $41.92 M |
| 05/08/2024 | Q1 2024 | -$0.19 | -$0.31 | -0.12 | $40.52 M | |
| 03/15/2024 | Q4 2023 | -$4.30 | $42.97 M | |||
| 11/02/2023 | Q3 2023 | -$0.45 | $38.27 M | $41.47 M | ||
| 08/08/2023 | Q2 2023 | -$0.34 | -$0.19 | 0.15 | $40.37 M | $44.30 M |
| 05/09/2023 | Q1 2023 | -$0.36 | -$0.71 | -0.35 | $37.92 M | |
| 03/16/2023 | Q4 2022 | -$0.34 | $39.62 M | |||
| 11/09/2022 | Q3 2022 | -$0.29 | $37.59 M | $40.26 M | ||
| 08/04/2022 | Q2 2022 | -$0.20 | $37.85 M | $39.66 M | ||
| 05/05/2022 | Q1 2022 | -$0.20 | $36.69 M | |||
| 03/10/2022 | Q4 2021 | -$0.40 | $35.82 M | |||
| 11/04/2021 | Q3 2021 | $0.04 | $36.32 M | $39.54 M | ||
| 08/05/2021 | Q2 2021 | $0.45 | $34.51 M | $38.15 M | ||
| 05/06/2021 | Q1 2021 | $0.20 | $34.29 M | |||
| 03/05/2021 | Q4 2020 | -$1.10 | $32.69 M | |||
| 11/04/2020 | Q3 2020 | -$0.45 | $30.11 M | $31.69 M | ||
| 08/07/2020 | Q2 2020 | -$0.54 | $20.37 M | $30.68 M | ||
| 05/22/2020 | Q1 2020 | $0.41 | $35.40 M | |||
| 03/05/2020 | Q4 2019 | $0.28 | $29.77 M |
Anika Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Anika Therapeutics, Inc.'s earnings date?
Anika Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 20th, 2025 based off last year's report dates.
-
How can I listen to Anika Therapeutics, Inc.'s earnings conference call?
The conference call for Anika Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Anika Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Anika Therapeutics, Inc.'s latest earnings report can be read online.
-
How much revenue does Anika Therapeutics, Inc. generate each year?
Anika Therapeutics, Inc. (:ANIK) has a recorded annual revenue of $166.66 M.
-
How much profit does Anika Therapeutics, Inc. generate each year?
Anika Therapeutics, Inc. (:ANIK) has a recorded net income of $166.66 M. Anika Therapeutics, Inc. has generated $-5.64 earnings per share over the last four quarters.
-
What is Anika Therapeutics, Inc.'s price-to-earnings ratio?
Anika Therapeutics, Inc. (:ANIK) has a price-to-earnings ratio of -2.57 and price/earnings-to-growth ratio is 0.08.
